1,900
Participants
Start Date
February 4, 2019
Primary Completion Date
February 1, 2023
Study Completion Date
June 30, 2024
Multi-analyte blood Test
intended for the qualitative detection of DNA methylation profiles associated with hepatocellular carcinoma in cell-free DNA derived from patient whole blood specimens.
VA Richmond, Richmond
Digestive & Liver Disease Specialists (DLDS) - Norfolk, Norfolk
PMG Research of Winston-Salem, Winston-Salem
Atlanta Gastroenterology, Atlanta
Piedmont Research Institute, Atlanta
University of Florida Clinical and Translational Science Institute, Gainesville
Covenant Metabolic LLC, Fort Myers
University of Miami - Schiff Center for Liver Diseases, Miami
Gastroenterology Group of Naples, Naples
Covenant Metabolics LLC, Sarasota
Quality Medical, Nashville
Gastro One in Memphis, Memphis
University of Louisville, Louisville
University of Cincinnati College of Medicine, Cincinnati
Loyola University Medical Center, Maywood
St Luke's Hospital of Kansas City, Kansas City
Kansas City Research Institute (KCRI), Kansas City
Tulane University Health Sciences Center, New Orleans
Ochsner Clinic Foundation, New Orleans
Louisiana Research Center, LLC, Shreveport
Liver Center of Texas, Dallas
Impact Research Institute, Waco
Konkord Research, Houston
Texas Liver Institute - American Research Corp., San Antonio
SouthTexas Research Institute, Edinburg
Methodist Dallas Medical Center, Dallas
Texas Gastro Clinic, El Paso
University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
AZ Liver Health (Chandler), Chandler
AZ Liver Health (Glendale, Peoria), Peoria
AZ Liver Health (Tucson), Tucson
Banner University Hospital (University of Arizona Tucson), Tucson
University of South California, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Alliance Research Centers, Irvine
Stanford University, Palo Alto
Harborview Medical Center (University of Washington), Seattle
Liver Institute Northwest, Seattle
Lead Sponsor
Helio Genomics
INDUSTRY